Regulation and litigation surrounding food and drug safety violations and practices before the U.S. FDA and courts.
By Colleen Murphy | January 10, 2025
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.
1 minute read
By Colleen Murphy | January 3, 2025
This action was surfaced by Law.com Radar, which delivers artificial intelligence-enhanced case summaries and daily case reports from more than 2,200 state and federal courts. Click here to get started and be among the first to act on opportunities in your region, practice area or client sector.
1 minute read
By Colleen Murphy | December 30, 2024
"Federal law requires defendants to ensure that their drug labels remain accurate, and when new scientific information renders their labels inaccurate, federal law requires defendants to act," the complaint said. "Failure to do so renders Oxbryta misbranded."
1 minute read
By Colleen Murphy | December 26, 2024
New Jersey-based pharmaceutical company UCB has sued to protect its patents for a Parkinson’s drug after an India-based company attempted to file an FDA application to create a generic version.
1 minute read
By Amanda Bronstad | November 21, 2024
After seven days of deliberations, a jury in Oakland, California, failed on Thursday to reach a verdict.
1 minute read
By Ross Todd | November 8, 2024
Juries hit Mead Johnson and Abbott Laboratories with verdicts of $60 million and $495 million respectively earlier this year in cases linking an intestinal disease with formula given to premature babies in hospitals. Covington's Phyllis Jones and Kirkland's Jim Hurst led teams that secured a defense verdict for the companies in Missouri state court last week.
11 minute read
By Riley Brennan | November 7, 2024
In "Daly v. Danone Waters of America," the court determined that the plaintiffs' claims were preempted by federal regulation.
5 minute read
By Ross Todd | November 1, 2024
After Andrew Soukup of Covington & Burling and Jay Lefkowitz of Kirkland & Ellis argued the motion to dismiss for the defendants, a federal judge in Brooklyn found state law claims concerning the effectiveness of decongestants were preempted by federal law and that the plaintiffs lacked standing to pursue their RICO claims.
13 minute read
By Amanda Bronstad | October 31, 2024
In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
5 minute read
By Amanda Bronstad | October 30, 2024
On Tuesday, U.S. District Judge Brian Cogan in New York dismissed key consumer claims in the multidistrict litigation against drugmakers of decongestants including Sudafed PE and NyQuil Severe Cold & Flu.
5 minute read
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Our client, a thriving personal injury firm known for its commitment to compassionate client care is seeking an attorney with 5+ years of ex...
McCarter and English s Chambers-ranked Government Contracts group is seeking an experienced, diligent, and proactive government contracts as...
The Court of Appeal, First Appellate District in San Francisco is accepting applications for a central staff attorney vacancy. A regular ful...
